Login
From:
Pulmonary Hypertension News
(Uncensored)
subscribe
FDA approves Yutrepia, inhaled treprostinil, for PAH and PH-ILD
https://pulmonaryhypertensionnews.com/news/fda-approves-yutrepia-inhaled-treprostinil-treat-pah-ph-ild/
links
backlinks
Tagged with:
fda approval
yutrepia
inhaled treprostinil
The FDA has approved Yutrepia, an inhaled treprostinil formulation, for the treatment of PAH and PH-ILD, two forms of pulmonary hypertension.
Roast topics
Find topics
Find it!
